What were Procter & Gamble Hygiene and Health Care Ltd's latest quarterly results?
Procter & Gamble Hygiene and Health Care Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +11.9%
- Revenue Growth YoY: +1.1%
- Operating Margin: 32.0%
Procter & Gamble Hygiene and Health Care Ltd (FMCG - Personal Care) — fundamental analysis, earnings data, and key metrics. PE: 34.5. ROE: 75.7%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Procter & Gamble Hygiene and Health Care Ltd's latest quarterly results (Dec 2025) show
Procter & Gamble Hygiene and Health Care Ltd's current PE ratio is 34.5x.
Procter & Gamble Hygiene and Health Care Ltd's price-to-book ratio is 31.8x.
Procter & Gamble Hygiene and Health Care Ltd's fundamental strength based on key financial ratios
Procter & Gamble Hygiene and Health Care Ltd has a debt-to-equity ratio of N/A.
Procter & Gamble Hygiene and Health Care Ltd's return ratios over recent years
Procter & Gamble Hygiene and Health Care Ltd's operating cash flow is positive (FY2025).
Procter & Gamble Hygiene and Health Care Ltd's current dividend yield is 1.86%.
Procter & Gamble Hygiene and Health Care Ltd's shareholding pattern (Dec 2025)
Procter & Gamble Hygiene and Health Care Ltd's promoter holding has remained stable recently.
Procter & Gamble Hygiene and Health Care Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Procter & Gamble Hygiene and Health Care Ltd may be worth studying
Procter & Gamble Hygiene and Health Care Ltd investment thesis summary:
Procter & Gamble Hygiene and Health Care Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.